BMS backs Stand Up To Cancer lung research

Share this article:

Bristol-Myers Squibb is kicking in $5 million to support a new lung cancer research “Dream Team.” The money is going toward a new collaboration between the American Cancer Society and the group Stand Up To Cancer.

The BMS contribution covers 20% of the Dream Team's three-year research budget.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.